In this study, we demonstrated that ANGPTL2-containing SEVs released from ECs support B-ALL development while ANGPTL2-mut#2-containing SEVs had no effects on B-ALL progression. Here, ANGPTL2 is linked to acute lymphoblastic leukemia.